Details for 2023210110
Up to date per 03.04.2026
Actions
Details for 2023210110
Granted/Registered
European Patent
03.01.2024 A
21.05.2025 B1
31.07.2009
US
23030809 P
C12N 9/64 20060101AFI20240318BHEP
Owner
Takeda Pharmaceutical Company Limited1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045JP
Representative
No representatives present
Inventor
Hasslacher, Meinhard 1020 WienAT
Mitterer, Artur 2304 Orth/DonauAT
Fiedler, Christian 1100 WienAT
Mayer, Christa 2412 WolfsthalAT
Information about Fees